Dovitinib (TKI-258): RTK Research Guide

2026-08-21

Dovitinib, also called TKI-258 and CHIR-258, is a multitargeted receptor tyrosine kinase inhibitor used to study FLT3, c-Kit, FGFR, VEGFR, and PDGFR signaling. Its reported nanomolar activity and downstream effects on ERK, STAT, and apoptosis pathways support research in multiple myeloma and hepatocellular carcinoma models, but they do not establish clinical efficacy.

Chemically Modified TPO mRNA Stimulates Thrombopoiesis

2026-08-20

Zhang and colleagues developed chemically modified, in-vitro-transcribed thrombopoietin mRNA and delivered it with lipid nanoparticles to increase platelet production in mice. The study links transient TPO expression with dose-dependent thrombopoiesis and rapid recovery from antibody-induced thrombocytopenia, while also illustrating the design requirements for therapeutic RNA workflows.

Amplex Red: H2O2 Detection and Assay Design

2026-08-20

Amplex Red, also known as 10-Acetyl-3,7-dihydroxyphenoxazine, is a fluorogenic hydrogen peroxide and peroxidase substrate that generates fluorescent resorufin. Its sensitivity is useful for reactive oxygen species detection, but NAD(P)H-dependent assays require controls because HRP-associated superoxide can create background signal.

Panobinostat Targets MLL-Rearranged ALL Epigenetics

2026-08-19

DHODH Inhibition in NPC: TP53-Dependent Effects

2026-08-19

Dong et al. identify pyrimidine biosynthesis and DHODH as therapeutically relevant features of nasopharyngeal carcinoma. Their combination of dataset analysis, pharmacological testing, transcriptomics, and TP53 knockdown shows that BAY2402234 suppresses NPC phenotypes through a TP53-dependent response.

NSC 87877 Workflows for Shp2 Signaling

2026-08-18

Use NSC 87877 to separate SHP2 catalytic phosphatase activity from adaptor-complex behavior in microglial, EGF–ERK, and disease-model experiments. This workflow emphasizes concentration design, orthogonal readouts, reference-study translation, and controls that prevent Shp1 activity or formulation issues from confounding interpretation.

Streptavidin-FITC in Cell Adhesion Assays

2026-08-18

Streptavidin-FITC converts biotinylated antibodies, proteins, and nucleic acid probes into a practical green-fluorescent readout for tissue imaging, cell phenotyping, and adhesion studies. This workflow-focused guide connects the product to recent ST3GAL1–sialylation research while distinguishing validated assay principles from experiment-specific recommendations.

SD 169: p38 MAPK Workflow Guide

2026-08-17

SD 169 (indole-5-carboxamide) offers a practical way to interrogate p38α/β signaling in inflammation, apoptosis, type 1 diabetes research, and nerve-injury models. This guide translates its ATP-competitive activity into assay-ready workflows while separating product-supported findings from optimization recommendations and emerging phosphatase-aware concepts.

GI Device Delivery of mRNA-LNPs in Mice and Pigs

2026-08-17

This 2024 study shows that ingestible microjet devices can deliver firefly luciferase mRNA–lipid nanoparticles into the stomach and intestinal walls of mice and minipigs. Gastrointestinal administration produced controlled release, plasma and lymph-node exposure, and route-dependent expression and biodistribution, supporting further investigation of needle-free mRNA delivery.

Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels

2026-08-16

Huang and colleagues evaluated acute and chronic sulfamonomethoxine toxicity across algae, cladocerans, and medaka, providing a cross-trophic comparison that had been limited for this aquaculture antibiotic. The results identify microalgae as particularly sensitive test organisms and support more careful assessment of antibiotic residues in aquaculture-affected waters.

Mitoxantrone: Assay Design Beyond ABCG2 Resistance

2026-08-15

Mitoxantrone is more than a cytotoxic topoisomerase II inhibitor: it is a useful mechanistic probe for separating target-mediated activity from ABCG2-driven drug efflux. This guide translates recent marein–ABCG2 findings into practical, transporter-aware oncology assay decisions.

SD 169: Practical p38 MAPK Workflows

2026-08-14

SD 169 (indole-5-carboxamide) gives researchers a focused way to interrogate p38α/β signaling in inflammatory, diabetes, Schwann-cell, and axonal regeneration models. This guide translates its ATP-competitive activity and emerging dual-action mechanism into practical assay designs, controls, and troubleshooting steps.

Dual Recombinase Tracing Excludes Mouse Neo-oogenesis

2026-08-14

Xie, Zhou, and Zheng use orthogonal Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in vivo. Across physiological aging and busulfan-induced ovarian injury, the study detected no contribution of labeled non-germline ovarian cells to growing oocytes or MII eggs, strengthening the case against postnatal neo-oogenesis in mice.

Tamoxifen in Mitochondrial Cancer Research

2026-08-13

Explore Tamoxifen as both a selective estrogen receptor modulator and a conditional genetic tool in cancer research. This article connects CreER design with mitochondrial iron, PINK1-dependent mitophagy, and more rigorous interpretation of tumor-cell assays.

Enzyme-Induced Hypoxia and Urothelial Inflammation

2026-08-13

Hudson and colleagues show that hypoxia duration determines whether rat urothelial cells develop a caspase-1-associated inflammatory response. Short exposure stabilized HIF-1α without detectable inflammasome activation, whereas prolonged exposure increased caspase-1 through a pathway attenuated by glutathione and Verapamil, supporting a ROS–TXNIP–NLRP3 mechanism.